These findings indicate that the identified gene set is associated with the presence of tertiary lymphoid structures (TLSs) and may also significantly enhance DFS in early-stage EGFR-mutant lung adenocarcinoma. This evidence concerns the gene EGFR and lung adenocarcinoma.